Considering the need for prognostic and predictive biomarkers to optimize the treatment decision and management of patients with PM, Ki67 tumor expression might facilitate the patient selection for surgical therapy in a multimodal setting and therefore increase prognosis and quality of life of PM patients. Here, MKI67 is linked to neoplasm.